Six-year Survival and HRQoL Outcomes with 1L Nivolumab (N) Plus Ipilimumab (I) Vs Chemotherapy (C) in Patients with Metastatic NSCLC (mnsclc) from CheckMate227
ONCOLOGY RESEARCH AND TREATMENT（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined